750 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
REGN Regeneron Pharmaceuticals, Inc. $432.64 $46.36B Uptrend
Article Searches
Wall Street Breakfast: U.S. Jobs Report - A Familiar Story? https://seekingalpha.com/article/4194309-wall-street-breakfast-u-s-jobs-report-familiar-story?source=feed_tag_wall_st_breakfast Aug 03, 2018 -
Company News For Aug 3, 2018 http://www.zacks.com/stock/news/315793/company-news-for-aug-3-2018?cid=CS-ZC--315793 Aug 03, 2018 - Companies in the news are: CI, TSLA, TEVA and REGN
Applied Genetic Technologies Corporation: Near-Term Run Up Expected https://seekingalpha.com/article/4189316-applied-genetic-technologies-corporation-near-term-run-expected?source=feed_sector_healthcare Jul 23, 2018 - Shares are trading at roughly a third of the original IPO price. Recent accumulation is indicative of further upside in the near term. Pessimism and past setbacks have led to an incredibly cheap valua
Intellia Therapeutics: Left Behind The Cas9 Excitement https://seekingalpha.com/article/4188960-intellia-therapeutics-left-behind-cas9-excitement?source=feed_sector_healthcare Jul 22, 2018 - NTLA is working to develop lipid nanoparticles for CRISPR delivery - a unique advantage. The company continues to progress, and has a strong cash reserve for the upcoming years. Without a Phase I tria
Allergan's Big Win For 12-Week Wet AMD Dosing With Abicipar May Be Enough To Pit It Against A Host Of Competitors https://seekingalpha.com/article/4188613-allergans-big-win-12-week-wet-amd-dosing-abicipar-may-enough-pit-host-competitors?source=feed_sector_healthcare Jul 20, 2018 - Allergan and Molecular Partners achieve positive results in two phase 3 studies using abicipar for treating patients with wet age-related macular degeneration.The primary endpoints for both phase 3 st
Pfizer & Lilly's Pain Candidate Succeeds in Phase III Study http://www.zacks.com/stock/news/312287/pfizer-lillys-pain-candidate-succeeds-in-phase-iii-study?cid=CS-ZC-FT-312287 Jul 19, 2018 - Pfizer (PFE) and Eli Lilly (LLY) announce that their investigational pain candidate, tanezumab, significantly reduces pain in osteoarthritis patients.
Cheap Stocks Moving In The Right Direction https://seekingalpha.com/article/4188010-cheap-stocks-moving-right-direction?source=feed_all_articles Jul 18, 2018 - What can be better than buying a cheap stock? Buying a cheap stock that is moving in the right direction.Introducing a quantitative system focused on companies with low PEG ratio and rising earnings e
Playing The Expectations Game In Biotech https://seekingalpha.com/article/4187892-playing-expectations-game-biotech?source=feed_all_articles Jul 17, 2018 - The biotechnology sector is fertile ground for highly profitable investments, but the downside risk in the sector is also above average.Since the dispersion in returns is so wide, picking the right in
Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug https://seekingalpha.com/article/4187810-gileads-hiv-franchise-assault-stares-paradigm-changing-drug?source=feed_sector_healthcare Jul 17, 2018 - Patent fight with Glaxo dampens Biktarvy sales.HIV franchise losing dominance to new entrants.Empty HIV pipeline could lead to acquisitions.PRO 140 represents paradigm changing drug.CytoDyn acquisitio
Allergan: Crucial Period Ahead For Company As Activist Pressure Mounts https://seekingalpha.com/article/4187408-allergan-crucial-period-ahead-company-activist-pressure-mounts?source=feed_sector_healthcare Jul 16, 2018 - Allergan is under pressure from activist shareholders and other investors to formulate a clear strategic plan and make more drastic changes to the company.Botox Aesthetics, Botox Migraine, and Restasi

Pages: 123456...75

Page 1>

Related Companies

Name Exchange Price Mkt Cap
SHPG Shire plc NASDAQ $155.08 $46.95B
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $151.24 $38.13B
ALXN Alexion Pharmaceuticals, Inc. NASDAQ $142.85 $31.88B
ZTS Zoetis Inc. NYSE $64.16 $31.38B
AGN Allergan plc. NYSE $204.65 $68.42B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Regeneron Pharmaceuticals